Prediabetes linked to excess glucagon in transgenic mice with pancreatic active AKT1.

about

Prediabetes linked to excess glucagon in transgenic mice with pancreatic active AKT1.

Item

http://www.wikidata.org/entity/Q36715658

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Prediabetes linked to excess glucagon in transgenic mice with pancreatic active AKT1.

@ast

Prediabetes linked to excess glucagon in transgenic mice with pancreatic active AKT1.

@en

type

Item

label

Prediabetes linked to excess glucagon in transgenic mice with pancreatic active AKT1.

@ast

Prediabetes linked to excess glucagon in transgenic mice with pancreatic active AKT1.

@en

prefLabel

Prediabetes linked to excess glucagon in transgenic mice with pancreatic active AKT1.

@ast

Prediabetes linked to excess glucagon in transgenic mice with pancreatic active AKT1.

@en

P1476

Prediabetes linked to excess glucagon in transgenic mice with pancreatic active AKT1.

@en

P2093

Deborah A Altomare

http://www.w3.org/2001/XMLSchema#string

Lina P Spinel

http://www.w3.org/2001/XMLSchema#string

Michal M Masternak

http://www.w3.org/2001/XMLSchema#string

Toya M Albury-Warren

http://www.w3.org/2001/XMLSchema#string

Veethika Pandey

http://www.w3.org/2001/XMLSchema#string

P2860

Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKB beta

Pancreatic α-Cell Dysfunction in Type 2 Diabetes: Old Kids on the Block

PI3K-PKB/Akt pathway

Diverse mechanisms of AKT pathway activation in human malignancy

Islet beta cell expression of constitutively active Akt1/PKB alpha induces striking hypertrophy, hyperplasia, and hyperinsulinemia

The homeodomain protein PDX1 is required at mid-pancreatic development for the formation of the exocrine pancreas

Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta)

Glucagon regulates hepatic kisspeptin to impair insulin secretion

Pathophysiology and pharmacological treatment of insulin resistance.

Experimental control of pancreatic development and maintenance.

P304

49-59

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1530/JOE-15-0288

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

228

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26487674

http://www.w3.org/2001/XMLSchema#string

P932

4803065

http://www.w3.org/2001/XMLSchema#string